October 31, 2026 · The American journal of medicine · DOI: 10.1016/j.amjmed.2026.10.031

Current development of therapeutic strategies for Alzheimer's disease.

Listen to this summary

This review surveys current therapeutic strategies for Alzheimer's disease, organized around a three-phase model: amyloid-β deposition, intraneuronal p-tau tangles, and downstream effector pathways causing neuronal damage. The author reports that anti-Aβ antibodies slowed cognitive decline by about 26% but caused brain swelling or hemorrhage in roughly 30% of patients, while anti-p-tau antibodies reduced tau burden without cognitive benefit. Early human and mouse studies of phase III targets (e.g., intersectin-1 inhibition, PD-1 blockade, and oxidative stress reduction) are also highlighted as promising directions.

Edward J Goetzl

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play